Dysregulation of the EphrinB2−EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients

[1]  Edward R. Smith,et al.  Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation , 2019, Neuron.

[2]  Vitor Mendes Pereira,et al.  Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain , 2018, The New England journal of medicine.

[3]  D. Zurakowski,et al.  Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. , 2016, Journal of neurosurgery. Pediatrics.

[4]  C. Germer,et al.  Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. , 2015, Cardiovascular research.

[5]  M. Moses,et al.  The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  J. Mulliken,et al.  Glucose Transporter 1‐Positive Endothelial Cells in Infantile Hemangioma Exhibit Features of Facultative Stem Cells , 2015, Stem cells.

[7]  Edward R. Smith,et al.  Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. , 2014, Cancer research.

[8]  Yuanli Zhao,et al.  Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation , 2014, The Journal of international medical research.

[9]  L. Ferrarini,et al.  EndMT contributes to the onset and progression of cerebral cavernous malformations , 2013, Nature.

[10]  N. Fineberg,et al.  A prospective population-based cohort study of the prevalence, incidence and impact of obsessive-compulsive symptomatology , 2013, International journal of psychiatry in clinical practice.

[11]  M. Klagsbrun,et al.  Netrin-1 Promotes Glioblastoma Cell Invasiveness and Angiogenesis by Multiple Pathways Including Activation of RhoA, Cathepsin B, and cAMP-response Element-binding Protein* , 2012, The Journal of Biological Chemistry.

[12]  D. Megías,et al.  Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. , 2012, Blood.

[13]  Don L. Armstrong,et al.  Thrombospondin-1 Modulates the Angiogenic Phenotype of Human Cerebral Arteriovenous Malformation Endothelial Cells , 2011, Neurosurgery.

[14]  G. Martiny-Baron,et al.  The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis , 2010, Angiogenesis.

[15]  A. Chervonsky,et al.  Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants , 2010, Genesis.

[16]  C. McCulloch,et al.  EPHB4 Gene Polymorphisms and Risk of Intracranial Hemorrhage in Patients With Brain Arteriovenous Malformations , 2009, Circulation. Cardiovascular genetics.

[17]  J. Elder,et al.  ABERRANT ANGIOGENIC CHARACTERISTICS OF HUMAN BRAIN ARTERIOVENOUS MALFORMATION ENDOTHELIAL CELLS , 2009, Neurosurgery.

[18]  H. Augustin,et al.  Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. , 2008, Blood.

[19]  D. Zurakowski,et al.  Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy , 2008, Clinical Cancer Research.

[20]  C. Warlow,et al.  Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study , 2008, The Lancet Neurology.

[21]  Edward R. Smith,et al.  A RECURRENT CRANIOPHARYNGIOMA ILLUSTRATES THE POTENTIAL USEFULNESS OF URINARY MATRIX METALLOPROTEINASES AS NONINVASIVE BIOMARKERS: CASE REPORT , 2007, Neurosurgery.

[22]  R. Klein,et al.  Bidirectional Eph-ephrin signaling during axon guidance. , 2007, Trends in cell biology.

[23]  P. Kuhn,et al.  Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. , 2006, Structure.

[24]  Gudrun Dandekar,et al.  Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells , 2003, Journal of Cell Science.

[25]  N. Barbaro,et al.  Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations , 2003, Stroke.

[26]  T. Suda,et al.  Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. , 2002, Blood.

[27]  Xiao-Hua Zhou,et al.  Statistical Methods in Diagnostic Medicine , 2002 .

[28]  G Garcia-Cardena,et al.  Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. , 2001, Developmental biology.

[29]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[30]  D. Anderson,et al.  Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.

[31]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[32]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[33]  J. Folkman,et al.  Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border , 1998, Cell.

[34]  I. Awad,et al.  Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. , 1996, Neurosurgery.

[35]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[36]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[37]  S. Mohapatra,et al.  Binary Logistic Regression , 2014 .

[38]  G. Owen,et al.  A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. , 2009, Biological research.

[39]  D. C. Henckel,et al.  Case report. , 1995, Journal.